Penserra Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,910
| Closed | -$68K | – | 1406 |
|
|
2021
Q3 | $68K | Buy |
1,910
+275
| +17% | +$9.79K | ﹤0.01% | 958 |
|
|
2021
Q2 | $32K | Buy |
1,635
+30
| +2% | +$587 | ﹤0.01% | 1085 |
|
|
2021
Q1 | $37K | Sell |
1,605
-20
| -1% | -$461 | ﹤0.01% | 868 |
|
|
2020
Q4 | $33K | Buy |
1,625
+1,021
| +169% | +$20.7K | ﹤0.01% | 754 |
|
|
2020
Q3 | $13K | Buy |
+604
| New | +$13K | ﹤0.01% | 791 |
|